Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00WKL
|
|||
Former ID |
DIB007290
|
|||
Drug Name |
PSX-4206
|
|||
Synonyms |
PSX-4159; VAP1 inhibitor (lung disease), Pharmaxis; Vascular adhesion protein-1 inhibitor (lung disease), Pharmaxis
Click to Show/Hide
|
|||
Indication | Pulmonary disease [ICD-11: 1B10-1F85; ICD-10: J00-J99; ICD-9: 460-519] | Investigative | [1] | |
Company |
Pharmaxis Ltd
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Membrane copper amine oxidase (AOC3) | Target Info | Inhibitor | [1] |
BioCyc | Phenylethylamine degradation I | |||
Spermine and spermidine degradation I | ||||
KEGG Pathway | Glycine, serine and threonine metabolism | |||
Tyrosine metabolism | ||||
Phenylalanine metabolism | ||||
beta-Alanine metabolism | ||||
Metabolic pathways | ||||
Panther Pathway | Phenylethylamine degradation | |||
Pathwhiz Pathway | Beta-Alanine Metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2767). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.